United Kingdom (UK) Companion Diagnostic Tests in Oncology Market (2025-2031) | Value, Segmentation, Trends, Growth, Companies, Industry, Outlook, Forecast, Analysis, Share, Size & Revenue, Competitive Landscape

Market Forecast By Detection Technique (DNA Detection, Others), By Biomarker (EGFR, KRAS, HER2, BRAF V600E, Others), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Liver Cancer, Melanoma, Others), By End-user (Hospitals, Specialty Clinics, Diagnostic Labs, Others) And Competitive Landscape
Product Code: ETC9941393 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Outlook
  • Market Size of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market, 2024
  • Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market, 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Revenues & Volume for the Period 2021- 2031
  • United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Trend Evolution
  • United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Drivers and Challenges
  • United Kingdom (UK) Companion Diagnostic Tests in Oncology Price Trends
  • United Kingdom (UK) Companion Diagnostic Tests in Oncology Porter's Five Forces
  • United Kingdom (UK) Companion Diagnostic Tests in Oncology Industry Life Cycle
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Detection Technique for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By DNA Detection for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Biomarker for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By EGFR for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By KRAS for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By HER2 for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By BRAF V600E for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Cancer Type for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Breast Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Lung Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Colorectal Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Liver Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Melanoma for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By End-user for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Specialty Clinics for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Diagnostic Labs for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume By Others for the Period 2021- 2031
  • United Kingdom (UK) Companion Diagnostic Tests in Oncology Import Export Trade Statistics
  • Market Opportunity Assessment By Detection Technique
  • Market Opportunity Assessment By Biomarker
  • Market Opportunity Assessment By Cancer Type
  • Market Opportunity Assessment By End-user
  • United Kingdom (UK) Companion Diagnostic Tests in Oncology Top Companies Market Share
  • United Kingdom (UK) Companion Diagnostic Tests in Oncology Competitive Benchmarking By Technical and Operational Parameters
  • United Kingdom (UK) Companion Diagnostic Tests in Oncology Company Profiles
  • United Kingdom (UK) Companion Diagnostic Tests in Oncology Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?
6Wresearch actively monitors the United Kingdom (UK) Companion Diagnostic Tests in Oncology Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United Kingdom (UK) Companion Diagnostic Tests in Oncology Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Do you also provide customisation in the market study?
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Overview

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market - Industry Life Cycle

3.4 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market - Porter's Five Forces

3.5 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By Detection Technique, 2021 & 2031F

3.6 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By Biomarker, 2021 & 2031F

3.7 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F

3.8 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By End-user, 2021 & 2031F

4 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in the UK, leading to higher demand for companion diagnostic tests in oncology.

4.2.2 Growing focus on personalized medicine and targeted therapies in oncology, driving the adoption of companion diagnostic tests.

4.2.3 Advancements in technology and biomarker research enhancing the accuracy and effectiveness of companion diagnostic tests.

4.3 Market Restraints

4.3.1 Stringent regulatory requirements and approval processes for companion diagnostic tests may slow down their market entry and adoption.

4.3.2 Limited reimbursement policies for companion diagnostic tests in oncology could hinder their widespread use.

5 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Trends

6 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market, By Types

6.1 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market, By Detection Technique

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Detection Technique, 2021- 2031F

6.1.3 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By DNA Detection, 2021- 2031F

6.1.4 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F

6.2 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market, By Biomarker

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By EGFR, 2021- 2031F

6.2.3 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By KRAS, 2021- 2031F

6.2.4 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By HER2, 2021- 2031F

6.2.5 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By BRAF V600E, 2021- 2031F

6.2.6 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F

6.3 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market, By Cancer Type

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.3.3 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.3.4 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F

6.3.5 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Liver Cancer, 2021- 2031F

6.3.6 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Melanoma, 2021- 2031F

6.3.7 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F

6.4 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market, By End-user

6.4.1 Overview and Analysis

6.4.2 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.4.4 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Diagnostic Labs, 2021- 2031F

6.4.5 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F

7 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Import-Export Trade Statistics

7.1 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Export to Major Countries

7.2 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Imports from Major Countries

8 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Key Performance Indicators

8.1 Average turnaround time for test results, impacting the efficiency and accessibility of companion diagnostic tests.

8.2 Number of partnerships and collaborations between diagnostic companies and pharmaceutical firms for developing and promoting companion diagnostic tests.

8.3 Adoption rate of novel biomarkers or technologies in companion diagnostic tests, indicating market acceptance and innovation.

9 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market - Opportunity Assessment

9.1 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By Detection Technique, 2021 & 2031F

9.2 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By Biomarker, 2021 & 2031F

9.3 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F

9.4 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By End-user, 2021 & 2031F

10 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market - Competitive Landscape

10.1 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Companion Diagnostic Tests in Oncology Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Related Report Available


×
Go to New Report No! I want to read this
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
Buy Now
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Search

Related Reports

Industry Events and Analyst Meet

4th Edition India Energy Conclave 2025

4th Edition India Energy Conclave 2025

Media Expo 2025

Media Expo 2025

Gas India Expo 2025

Gas India Expo 2025

Consumer Electronics World Expo 2025

Consumer Electronics World Expo 2025

Gifts World Expo 2025

Gifts World Expo 2025

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All

6WResearch In News

Read All
About Us

6Wresearch is the premier, one stop market intelligence and advisory center, known for its best in class business research and consulting activity. We provide industry research reports and consulting service across different industries and geographies which provide industry players an in-depth coverage and help them in decision making before investing or enter into a particular geography.

  • twitter logo
  • facebook logo
  • linkedin logo
Company
About Us
Events
Careers
Privacy Policy
Terms & Conditions
Delivery
Disclaimer
Contact Us
Services
ADVISORY & CONSULTING
FEASIBILITY STUDIES & BUSINESS PLAN
COMPETITORS INTELLIGENCE
CHANNEL & DISTRIBUTION STRATEGY
PROCUREMENT INTELLIGENCE
CUSTOMER BEHAVIOR ANALYSIS
BUSINESS MODELS & KEY MANAGEMENT PRACTICES
CRITICAL SUCCESS FACTORS ANALYSIS
Verticals
Aerospace and Defense
Chemicals and Materials
Semiconductor and Electronics
Power, Utility and Oil & Gas
Heavy Industry
Telecom, Information & Communication Technology
Healthcare
Automotive
Consumer Staples
Banking, Financial and Legal Services
Metals and Minerals
Media and Entertainment
Miscellaneous
©2025 6Wresearch, All Right Reserved